SLC6A4 and post-traumatic stress disorder: Many genetic studies of PTSD to date have focused on the serotonin system, as PTSD can be treated by targeting the serotonin transporter (SLC6A4) with selective-serotonin reuptake inhibitors (SSRIs) [7], [8].